Hong Kong MDACS Guidance Updated! All Changes at a Glance
Views:86
Time:2026-11-12 15:45:15


The Medical Devices Division of the Department of Health has released a full set of updated GN guidance documents for MDACS. This revision adjusts rules covering listing, Local Responsible Person (LRP), traders, IVDs, post-market incident reporting and more. Manufacturers already selling in Hong Kong or planning MDACS listing are advised to focus on these regulatory changes and update your compliance strategy accordingly.



原
文
链
接


https://www.mdd.gov.hk/tc/whats-new/documents-forms-updates/index-id-2377.html

一、About MDACS



The Medical Device Administrative Control System (MDACS) is a voluntary listing scheme administered by the Hong Kong Department of Health, built on the IMDRF (formerly GHTF) international medical device regulatory framework. It has two core components: listing for devices/traders and post-market surveillance via medical incident reporting.
Important note: While the scheme is voluntary, starting from 23 March 2026, medical devices procured by the Hospital Authority must be MDACS-listed. In practice, MDACS listing has become a critical market access requirement for Hong Kong.

Eligible for listing:
  • General Medical Devices (GMD): Class II, III, IV (Class I excluded; Class IV carries the highest risk)
  • In Vitro Diagnostic Medical Devices (IVDMD): Class B, C, D (Class A excluded; Class D carries the highest risk)

Outside the scope of MDACS (specified in GN‑01):pharmaceutical products, human blood/tissue products, animal-derived implantable products, standard PPE, cosmetics, refurbished devices, custom-made devices, and devices solely for research, teaching or demonstration purposes. Even if they meet the definition of a medical device, they are not eligible for MDACS listing.
二、GN‑02 Listing of Class II/III/IV General Medical Devices | Key Updates



  • Documentation requirements for the two listing pathways are further refined:
    1. Certificate issued by a Hong Kong recognised Conformity Assessment Body (CAB)
    2. Valid overseas marketing approvals (from IMDRF members, NMPA, MFDS, HSA etc.) with updated Essential Principles checklist requirements, including explicit guidance on unacceptable certificates.
  • Approval outcomes are restated: approval, conditional approval and rejection. Common conditions for conditional approval are listed, such as supplementary data, restricted intended use and ongoing post-market surveillance.
  • Renewal window is strictly enforced: renewal applications may only be submitted between 12 weeks and 1 year before expiry. No late applications will be accepted. Once expired, a brand-new application must be filed.
  • Rules for HKMD number marking are updated: a 6-month grace period after listing approval. Requirements for font size, placement and bilingual labelling wording are revised. Marketing communications must not claim Hong Kong government endorsement of safety or performance; only the MDACS listing status and HKMD number may be stated.
三、GN‑03 Medical Incident Reporting | Key Updates



  • Two prerequisites for mandatory reporting: the incident occurs in Hong Kong, and the device is MDACS-listed.
  • Reporting deadlines remain unchanged, with a new preliminary report + final report mechanism. Submit a preliminary report by the deadline, then follow up with full investigation findings once available, to avoid overdue submissions while investigations are ongoing.
    • Death / serious injury / major public health risk: report within 10 calendar days
    • Other reportable incidents: report within 30 calendar days
  • The list of report exemptions is expanded. Critical new rule: a single incident may be exempted, but recurring incidents linked to the same defect must be reported as a trend.
  • The LRP is defined as the primary responsible party for reporting. Importers and distributors must notify the LRP promptly and let the LRP coordinate the submission, clarifying responsibilities across the supply chain.
四、GN‑04 Conformity Assessment Framework and CABs | Key Updates



  • Updated rules for CAB admission, ongoing surveillance, suspension and revocation of recognition.
  • Clarified validity periods, certificate amendments and transition arrangements when switching CABs. CAB certificates will be synchronised to the MDIS system for DH verification.
  • New requirement: CAB assessment reports must clearly state applicable standards, risk class and essential principles, to reduce application rejection caused by incomplete certificates.
五、GN‑06 Listing of Class B/C/D IVD Medical Devices | Key Updates



  • Refined IVD risk classification criteria, distinguishing clinical-use and self-test IVDs.
  • Updated document checklist for the overseas reference route, with separate requirements for reagents, instruments and accessory components.
  • Labelling, IFU and HKMD marking rules are aligned with general medical devices, including the same 6-month grace period.
  • More detailed submission requirements for renewals and variations (model, specification, intended use, manufacturer changes).
六、GN‑07 Importer Listing | Key Updates



  • Importer listing is voluntary, valid for 3 years, with the same strict renewal window: 12 weeks to 1 year before expiry.
  • New mandatory SOP modules: device traceability, warehouse temperature & humidity control, quarantine of non-conforming stock, recall coordination, incident escalation, complaints handling, and tracking for high-risk devices.
  • Clear statement: importer listing ≠ device listing. Misleading marketing is prohibited. DH may conduct on-site inspections of warehouses and records.
  • Record retention rule: supply records shall be kept for the longer of the product shelf life or 7 years after supply to a third party.
七、GN‑08 Local Manufacturer Listing | Key Updates



  • Valid for 5 years, with renewal rules aligned with device listing.
  • Updated focus areas for quality system review: ISO 13485 documentation, internal change control, design changes, release control and non-conforming product management.
  • Where a local manufacturer also acts as the LRP, dual responsibilities apply and the two sets of records must be separately traceable.
GN‑09 Distributor Listing | Key Updates
八、GN‑09 Distributor Listing | Key Updates



  • Valid for 3 years, with the same renewal window as importers.
  • New rule: distributors must not alter packaging or labels. Repackaging means the entity is no longer a simple distributor and requires separate assessment.
  • Distributors must establish fast escalation procedures for complaints, adverse events and recall notices and notify the LRP / importer promptly; distributors are not authorised to resolve these matters independently.
  • Strengthened warehouse and transport controls, with explicit temperature record retention requirements for cold-chain devices.
十、Key Reminders for This Update



Common pitfalls to avoid:
  • The newly issued COPs are binding compliance documents, not merely guidance. LRPs and traders must operate in accordance with the relevant COPs.
  • The renewal window is a hard deadline; there is no remedy once the listing expires.
  • Exemption from reporting does not mean exemption from documentation. Trend clusters of similar incidents still require reporting.
  • Marketing rules are tightened: no overstatement of the significance of MDACS listing.
  • Trader listing and product listing are independent statuses and must be clearly distinguished in all promotional materials.

Transition arrangement:Applications under review and already approved MDACS listings do not need re-submission. All new applications, variations and renewals will be assessed against the updated GN and COP documents.
十一、Closing



This round of MDACS revisions fills regulatory gaps and strengthens accountability for all supply chain participants. Manufacturers targeting Hong Kong markets are recommended to review your existing documents, SOPs and labelling against the new GN and COPs, prepare in advance for renewals and incident reporting workflows, mitigate compliance risks and achieve smooth Hong Kong market access.Please contact Wiselink for further enquiries.


Contact Us
Fill Form
Whether you need more information or wish to cooperate with us, we will guide you through every step of the regulatory process. Subscribe to our newsletter for the latest global regulatory updates.